Matinas BioPharma to Present at Biotech Showcase™ 2017
Jan 06, 2017 12:35 pm UTC| Business
BEDMINSTER, N.J., Jan. 06, 2017 -- Matinas BioPharma Holdings, Inc. (OTCQB:MTNB), clinical-stage biopharmaceutical company focused on developing innovative anti-infectives for orphan indications, announced today that...
Avinger Announces Preliminary Fourth Quarter 2016 Results
Jan 06, 2017 12:30 pm UTC| Business
REDWOOD CITY, Calif., Jan. 06, 2017 -- Avinger, Inc. (NASDAQ:AVGR), a leading developer of innovative treatments for peripheral artery disease (“PAD”), today announced that based on preliminary unaudited financial...
Dermira Provides Corporate Update
Jan 06, 2017 12:30 pm UTC| Business
Treatment period for DRM04 ARIDO trial completedPhase 3 acne clinical program for olumacostat glasaretil initiatedTopline data for third and final CIMZIA® (certolizumab pegol) Phase 3 trial expected first quarter of...
Cytori Therapeutics to Provide Corporate Update at 2017 Biotech Showcase™
Jan 06, 2017 12:30 pm UTC| Business
SAN DIEGO, Jan. 06, 2017 -- Cytori Therapeutics, Inc. (NASDAQ:CYTX) announced today that the company will present at the Biotech Showcase™ at 4:00 PM Pacific Time (7:00 PM Eastern Time) on Tuesday, January 10, 2017. The...
Monro Muffler Brake, Inc. to Present at the 19th Annual ICR Conference
Jan 06, 2017 12:30 pm UTC| Business
ROCHESTER, N.Y., Jan. 06, 2017 -- Monro Muffler Brake, Inc. (Nasdaq:MNRO), a leading provider of automotive undercar repair and tire services, today announced that Robert Gross, Executive Chairman, will present at the...
Stein Mart, Inc. Reports November/December Sales
Jan 06, 2017 12:30 pm UTC| Business
JACKSONVILLE, Fla., Jan. 06, 2017 -- Stein Mart, Inc. (NASDAQ:SMRT) today announced that its comparable store sales for the nine-week period ended December 31, 2016 decreased 4.8 percent and total sales decreased 1.9...
Pacira Pharmaceuticals Reports Preliminary 2016 Revenues of $276.4 Million
Jan 06, 2017 12:30 pm UTC| Business
PARSIPPANY, N.J., Jan. 06, 2017 -- Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) today reported preliminary unaudited total revenues and EXPAREL® (bupivacaine liposome injectable suspension) net product sales for the...